Back
ESC Premium Access

Risk of qtc interval prolongation among cancer patients treated with tyrosine kinase inhibitors

Session: Cardiovascular pharmacotherapy
Topic: Cardiotoxicity of Drugs
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

6 more presentations in this session

Research Network in Africa (RNA): quality assessment of antihypertensive generic drugs in 10 African countries

Speaker: Doctor D. Macquart de Terline (Paris, FR)

Access
Abstract
Like
Thumbnail

Clinical pharmacology of AZD9977, a novel, selective mineralocorticoid receptor (MR) modulator without K+-sparing properties

Speaker: Doctor A. Whittaker (Gothenburg, SE)

Access
Abstract
Like
Thumbnail

Impact on the prognosis of treatment administrated in the daily clinical practice to patients with myocardial infarction with non-obstructive coronary arteries.

Speaker: Doctor J. Lopez-Pais (Santiago de Compostela, ES)

Access
Abstract
Slides
Like
Thumbnail

Trends in indications and outcome in thrombolytic therapy: a retrospective single center study

Speaker: Doctor M. Engelen (Leuven, BE)

Access
Abstract
Slides
Like
Thumbnail

Cardioprotective anti inflammatory effects of empaglifozin in doxorubicin induced cardiotoxicity: the role of leukotriene B4 and interleukin 1

Speaker: Doctor N. Maurea (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiovascular pharmacotherapy

Speakers: Doctor D. Macquart de Terline, Doctor A. Whittaker, Doctor J. Lopez-Pais, Doctor M. Engelen, Doctor N. Maurea
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources